RRRSX
Price
$21.52
Change
+$0.02 (+0.09%)
Updated
Dec 3 closing price
Net Assets
948.07M
VGSNX
Price
$19.78
Change
+$0.05 (+0.25%)
Updated
Dec 3 closing price
Net Assets
64B
Interact to see
Advertisement

RRRSX vs VGSNX

Header iconRRRSX vs VGSNX Comparison
Open Charts RRRSX vs VGSNXBanner chart's image
DWS RREEF Real Estate Securities R
Price$21.52
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets948.07M
Vanguard Real Estate Index Institutional
Price$19.78
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets64B
RRRSX vs VGSNX Comparison Chart in %
View a ticker or compare two or three
VS
RRRSX vs. VGSNX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRRSX is a Buy and VGSNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 64B vs. RRRSX (948M). VGSNX pays higher dividends than RRRSX: VGSNX (3.88) vs RRRSX (2.21). RRRSX was incepted earlier than VGSNX: RRRSX (22 years) vs VGSNX (22 years). RRRSX (1.30) is less costly to investors than VGSNX (0.11). RRRSX is a more actively managed with annual turnover of: 106.00 vs. VGSNX (7.00). RRRSX has a lower initial minimum investment than VGSNX: RRRSX (0) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : -3.06 vs. RRRSX (-6.34). VGSNX return over 5 years is better than : 28.56 vs. RRRSX (13.15).
RRRSXVGSNXRRRSX / VGSNX
Total Expense Ratio1.300.111,182%
Annual Report Gross Expense Ratio1.300.111,182%
Fund Existence22 years22 years-
Gain YTD0.6444.25215%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets948M64B1%
Annual Yield % from dividends2.213.8857%
Returns for 1 year-6.34-3.06207%
Returns for 3 years13.6916.7782%
Returns for 5 years13.1528.5646%
Returns for 10 years11.0361.5518%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACU37.240.69
+1.87%
Acme United Corp
MAX12.740.12
+0.94%
MediaAlpha
STZ137.900.03
+0.02%
Constellation Brands
ADXN8.05-0.15
-1.83%
Addex Therapeutics Ltd
TLX9.51-0.32
-3.21%
Telix Pharmaceuticals Ltd.